Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

Use of Complementary and Alternative Therapies in Outpatients with Atopic Dermatitis from a Dermatological University Department

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Virtual Clinical Trials: Perspectives in Dermatology

    Research output: Contribution to journalReviewResearchpeer-review

  2. Socioeconomic Costs and Health Inequalities from Psoriasis: A Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Association between Atopic Dermatitis and the Metabolic Syndrome: A Systematic Review

    Research output: Contribution to journalReviewResearchpeer-review

  4. Th17 Inhibitors in Active Psoriatic Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Cytokine concentration across the stratum corneum in atopic dermatitis and healthy controls

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Ciclosporin

    Research output: Book/ReportReportCommissioned

  3. Factors associated with citation of original articles in 5 high-impact-factor dermatology journals

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Treatment of atopic dermatitis (AD) may be challenging, therefore some patients seek complementary and alternative medications (CAM). We determined prevalence and predictors for CAM use in a hospital cohort of AD patients.

MATERIAL AND METHODS: Between January 1, 2012, and December 31, 2017, AD patients referred to the dermatological outpatient clinic at Bispebjerg Hospital were included in the study. Information on CAM use, demographics and disease characteristics were obtained by questionnaire, and associations were determined by χ2 and t test separately for children (< 16 years) and adults (≥16 years).

RESULTS: In total 441 filled in the questionnaire on AD, and 433 patients responded to the questions about CAM use: 198 children and 235 adults. A total of 137 (31.6%) had used one or more CAM. CAM use in children was significantly associated with prior use of ≥2 conventional treatments (p = 0.047) and topical calcineurin inhibitors (p = 0.021), a higher number of affected eczema sites (p < 0.001) including more frequent affection of the face and extremities, a higher SCORAD score (p = 0.045), and low mean overall self-rated health (p = 0.003). CAM use in adults was significantly associated with lower age of onset of AD (p = 0.004), comorbid allergic rhinoconjunctivitis (p = 0.039), frequent use of moisturizing cream (p = 0.024), facial and neck eczema (p = 0.005) and high educational level (p = 0.043).

CONCLUSION: CAM use is frequent in both children and adult AD patients. CAM users are characterized by long disease duration, a significant disease burden and by having a longer education. The high prevalence of CAM may indicate that patients' expectations regarding treatment of AD are not redeemed in the conventional health care system.

Original languageEnglish
JournalDermatology
Volume235
Issue number3
Pages (from-to)189-195
Number of pages7
ISSN1018-8665
DOIs
Publication statusPublished - 2019

    Research areas

  • Adult, Age Factors, Ambulatory Care/methods, Child, Cohort Studies, Complementary Therapies/methods, Dermatitis, Atopic/diagnosis, Female, Follow-Up Studies, Hospitals, University, Humans, Male, Outpatients/statistics & numerical data, Quality of Life, Retrospective Studies, Risk Assessment, Severity of Illness Index, Sex Factors, Sickness Impact Profile, Switzerland, Treatment Outcome

ID: 59085313